Purple Biotech (1YI0) Q2 2024 Earnings Report
DE:1YI0 Q2 2024 EPS Results
- Actual EPS
- -EUR 16.12
- Consensus EPS
- -EUR 20.59
- Beat/Miss
- Beat by +EUR 4.48
- One Year Ago EPS
- -EUR 44.77
DE:1YI0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/16/2024
- Time
- Before Open
- Conference Call
- Friday, August 16, 2024
DE:1YI0 Upcoming Earnings
Purple Biotech's next earnings date is estimated for November 13, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1YI0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 13, 2026 | 2026 (Q3) | -2.58- | -2.6 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | -0.88-0.37 | -3.58 | 89.75% (+3.21) | |
| May 15, 2026 | 2026 (Q1) | -0.34-0.08 | -1.52 | 94.71% (+1.44) | |
| Mar 13, 2026 | 2025 (Q4) | -3.04-17.77 | -2.33 | -663.46% (-15.45) | |
| Nov 14, 2025 | 2025 (Q3) | -2.33-2.60 | -3.49 | 25.64% (+0.90) | |
| Aug 06, 2025 | 2025 (Q2) | -1.88-3.58 | -16.12 | 77.78% (+12.54) | |
| May 21, 2025 | 2025 (Q1) | ―-1.52 | -25.07 | 93.93% (+23.55) | |
| Mar 10, 2025 | 2024 (Q4) | -1.97-2.33 | -34.03 | 93.16% (+31.70) | |
| Nov 15, 2024 | 2024 (Q3) | -10.74-3.49 | -41.19 | 91.52% (+37.70) | |
| Aug 16, 2024 | 2024 (Q2) | -20.59-16.12 | -44.77 | 64.00% (+28.65) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
